Vol. 1 No. 1 (2021): Precision Medicine Communications

View Vol. 1 No. 1 (2021): Precision Medicine Communications

Published: 2021-12-30

Editorial

Welcome to Precision Medicine Communications!

Sagheer Ahmed

01

In This Issue

Editor's Summaries of the Articles Published in This Issue of Precision Medicine Communications

Editorial Staff

03-04

Editor's Choice

Cost of Pharmacogenetic-Guided Therapy in Type-2 Diabetes Mellitus

Editorial Staff

05-07
Hepatic Adverse Effects and Genetic Polymorphisms of NAT2 and CYP2C9

Editorial Staff

05-07
Genetic Polymorphisms in GABRD and Treatment Response and Dose in Methadone Maintenance Treatment

Editorial Staff

05-07
- PDF
Novel Genetic Variants Associated With Cardiovascular Events in Clopidogrel and Aspirin Users

Editorial Staff

05-07
MTHFR Gene Polymorphisms and Response to Chemotherapy in Metastatic Colorectal Cancer

Editorial Staff

05-07
- PDF

Research Articles

Polymorphism in the P2Y12 Gene & Antiplatelet Response to Clopidogrel in the Pakistani Population

Manzoor Ahmed, Muhammad Hanif Bangash, Mehwish Rafique

09-16
- PDF
Genetic Variations and Drug-Induced Liver Injury in Patients on Simvastatin

Muhammad Naeem Riaz, Rehan Ullah Salar, Halim Ur Rehman, Sadia Noor

17-23
- PDF

Review Articles

Parkinson’s Disease Treatment and the Role of Genetic Polymorphisms in the Efficacy and Adverse Effects

Halima Usman, Tooba Khalid, Amama Ghaffar

25-47
Pharmacogenetics of Fluoxetine; A Review of the Genetic Effects on Its Efficacy and Adverse Effects During Treatment of Major Depressive Disorder

Inzemam Khan, Saad Salman, Sayyed Muhammad Ashhad Halimi, Imran Khan, Kamran Ud Din

49-69
- PDF
Genetic Variations and Warfarin Dosing

Aman Ullah, Abdul Mateen, Muhammad Yasir Ghani Khan, Ismail Badshah

71-80